• DNDi_Logo_No-Tagline_Full Colour
  • Our work
    • Diseases
      • Sleeping sickness
      • Visceral leishmaniasis
      • Cutaneous leishmaniasis
      • Chagas disease
      • Filaria: river blindness
      • Mycetoma
      • Dengue
      • Paediatric HIV
      • Cryptococcal meningitis
      • Hepatitis C
      • Pandemic preparedness
      • Antimicrobial resistance
    • Research & development
      • R&D portfolio & list of projects
      • Drug discovery
      • Translational research
      • Clinical trials
      • Registration & access
      • Treatments delivered
    • Advocacy
      • Open and collaborative R&D
      • Transparency of R&D costs
      • Pro-access policies and IP
      • Children’s health
      • Gender equity
      • Climate change
      • AI and new technologies
  • Networks & partners
    • Partnerships
      • Our partners
      • Partnering with us
    • Global networks
      • Chagas Platform
      • Dengue Alliance
      • HAT Platform
      • LEAP Platform
      • redeLEISH Network
    • DNDi worldwide
      • DNDi Switzerland
      • DNDi Eastern Africa
      • DNDi Japan
      • DNDi Latin America
      • DNDi North America
      • DNDi South Asia
      • DNDi South-East Asia
      • DNDi West and Central Africa
  • News & resources
    • News & stories
      • News
      • Stories
      • Statements
      • Viewpoints
      • Social media
      • eNews Newsletter
    • Press
      • Press releases
      • In the media
      • Podcasts, radio & TV
      • Media workshops
    • Resources
      • Scientific articles
      • Our publications
      • Videos
    • Events
  • About us
    • About
      • Who we are
      • Our story
      • How we work
      • Our strategy
      • Our donors
      • Annual reports
      • Our prizes and awards
    • Our people
      • Our leadership
      • Our governance
      • Contact us
    • Work with us
      • Working at DNDi
      • Job opportunities
      • Requests for proposal
  • Donate
  • DNDi_Logo_No-Tagline_Full Colour
  • Our work
    • Diseases
      • Sleeping sickness
      • Visceral leishmaniasis
      • Cutaneous leishmaniasis
      • Chagas disease
      • Filaria: river blindness
      • Mycetoma
      • Dengue
      • Paediatric HIV
      • Cryptococcal meningitis
      • Hepatitis C
      • Pandemic preparedness
      • Antimicrobial resistance
    • Research & development
      • R&D portfolio & list of projects
      • Drug discovery
      • Translational research
      • Clinical trials
      • Registration & access
      • Treatments delivered
    • Advocacy
      • Open and collaborative R&D
      • Transparency of R&D costs
      • Pro-access policies and IP
      • Children’s health
      • Gender equity
      • Climate change
      • AI and new technologies
  • Networks & partners
    • Partnerships
      • Our partners
      • Partnering with us
    • Global networks
      • Chagas Platform
      • Dengue Alliance
      • HAT Platform
      • LEAP Platform
      • redeLEISH Network
    • DNDi worldwide
      • DNDi Switzerland
      • DNDi Eastern Africa
      • DNDi Japan
      • DNDi Latin America
      • DNDi North America
      • DNDi South Asia
      • DNDi South-East Asia
      • DNDi West and Central Africa
  • News & resources
    • News & stories
      • News
      • Stories
      • Statements
      • Viewpoints
      • Social media
      • eNews Newsletter
    • Press
      • Press releases
      • In the media
      • Podcasts, radio & TV
      • Media workshops
    • Resources
      • Scientific articles
      • Our publications
      • Videos
    • Events
  • About us
    • About
      • Who we are
      • Our story
      • How we work
      • Our strategy
      • Our donors
      • Annual reports
      • Our prizes and awards
    • Our people
      • Our leadership
      • Our governance
      • Contact us
    • Work with us
      • Working at DNDi
      • Job opportunities
      • Requests for proposal
  • Donate
Home > Events

World Hepatitis Summit 2022

7-10 June 2022

Virtual event

The World Hepatitis Summit (WHS) is an innovative, large-scale, global meeting to advance the viral hepatitis agenda and provide a platform for a broad hepatitis community to take stock of progress to date, share ideas, experiences and best practice in addressing the many challenges of viral hepatitis.

This year’s theme is ‘Achieving the elimination of viral hepatitis within evolving health systems‘.

Session

Viral hepatitis response in the Pan American region: Experiences from the Civil Society

Date: Thursday, 9 June 2022
Time: 17:20-18:30

Chairs: Sergio Sosa-Estani, Latin America Regional Director, DNDi and Su Wang, World Hepatitis Alliance and Center for Asian Health and Viral Hepatitis Programs at Cooperman Barnabas Medical Center, USA

The experience of Achcu civil organization in Uruguay
Victoria Izquierdo, Asociación Comunidad Hepatitis C, Uruguay
Building and advocating for a national law for viral hepatitis
Maria Eugenia De Feo Moyano, Fundaciòn HCV Sin Fronteras, Argentina
ALEH: Project for micro elimination of hepatitis C in dialysis patients
Marcelo Silva, Latin American Association for the Study of the Liver (ALEH)
Canada’s progress toward viral hepatitis elimination 2021 report: Holding governments accountable
Sofia Bartlett and Jennifer Van-Gennip, Action Hepatitis Canada, Canada

Panel discussion

Role of civil society in accelerating the hepatitis agenda in the Region

Date: Thursday, 9 June 2022
Time: 11.30-12.00

Moderator: Po-Lin Chan, WHO

Panelists:

  • RP Shanmugam, Chennai Liver Foundation, World Hepatitis Alliance, SEARO Board Member (India)
  • Giten Khwairakpam, Treat Asia, Thailand
  • Han Yang Chung, Senior Access & Advocacy Officer, DNDi
  • Khin Pyone, Myanmar Liver Foundation (TBC)

Presentations

Date: Wednesday, 8 June 2022
Time: 17.07-17.14

Going beyond low-hanging fruit: Key population-specific strategies to tackle hepatitis C in Malaysia
Radzi Abu Hassan M*, Keat Chan H, Yang Chung H, Azlan A
*Presenting author

Date: Thursday, 9 June 2022
Time: 09.00-09.15

Malaysia’s journey to hepatitis C elimination: From compulsory licensing to treatment decentralization
Muhammad Radzi bin Abu Hassan, Ministry of Health Malaysia

Poster

A global coalition to accelerate sustainable financing for hepatitis C elimination
Garrett GS, Diap G

More information

  • Hepatitis C PACT Presentations and Posters at World Hepatitis Summit 2022
  • Event website

Hepatitis C

Other events

Loading...
10-21 November 2025

Belém, Brazil

COP30

9-13 November 2025

Toronto, Canada

ASTMH 2025

6 November 2025, 3:00 PM Nairobi

Online

Bridging the gap between research and policy for NTDs amid a changing funding landscape

4-6 November 2025

Antwerp, Belgium & online

65th ITM Colloquium

See all

Stay connected

Get our latest news, personal stories, research articles, and job opportunities. 

Linkedin-in Instagram Twitter Facebook-f Youtube
International non-profit developing safe, effective, and affordable treatments for the most neglected patients.

Learn more

  • Diseases
  • Neglected tropical diseases
  • R&D portfolio
  • Policy advocacy

Get in touch

  • Our offices
  • Contact us
  • Integrity Line

Support us

  • Donate
  • Subscribe to eNews

Work with us

  • Join research networks
  • Jobs
  • RFPs
  • Terms of Use   
  •   Acceptable Use Policy   
  •   Privacy Policy   
  •   Cookie Policy   
  •   Our policies   

  • Except for images, films, and trademarks which are subject to DNDi’s Terms of Use, content on this site is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International license